Page last updated: 2024-10-28

hexylresorcinol and Schistosomiasis

hexylresorcinol has been researched along with Schistosomiasis in 2 studies

Schistosomiasis: Infection with flukes (trematodes) of the genus SCHISTOSOMA. Three species produce the most frequent clinical diseases: SCHISTOSOMA HAEMATOBIUM (endemic in Africa and the Middle East), SCHISTOSOMA MANSONI (in Egypt, northern and southern Africa, some West Indies islands, northern 2/3 of South America), and SCHISTOSOMA JAPONICUM (in Japan, China, the Philippines, Celebes, Thailand, Laos). S. mansoni is often seen in Puerto Ricans living in the United States.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Webbe, G1
Cuckler, AC1
Mezey, KC1

Reviews

1 review available for hexylresorcinol and Schistosomiasis

ArticleYear
The therapeutic efficacy of thiabendazole for helminthic infections in man; a literature review.
    Arzneimittel-Forschung, 1966, Volume: 16, Issue:3

    Topics: Ascariasis; Bephenium Compounds; Dithiazanine; Helminthiasis; Hexylresorcinol; Hookworm Infections;

1966

Other Studies

1 other study available for hexylresorcinol and Schistosomiasis

ArticleYear
Human trematode infections.
    The Journal of tropical medicine and hygiene, 1984, Volume: 87, Issue:4

    Topics: Anthelmintics; Asia, Southeastern; Bithionol; Clonorchiasis; Hexylresorcinol; Humans; Opisthorchiasi

1984